Skip to main content
. 2021 Oct 27;13(11):1800. doi: 10.3390/pharmaceutics13111800

Table 3.

FICI for the synergistic effect of PapMA-3 in combination with antibiotics against CRABs.

PapMA-3 with
Antibiotics
MIC (μg·mL−1) MIC in Combination (μg·mL−1)
Strain PapMA-3 Antibiotics PapMA-3 Antibiotics FICI #
PapMA-3 + Imipenem CRAB C1 16 64 4.0 4.0 0.31 *
CRAB C2 16 64 4.0 8.0 0.38
CRAB C3 16 64 8.0 1.0 0.52
CRAB C4 32 64 8.0 8.0 0.38
CRAB C5 16 64 8.0 16 0.75
PapMA-3 + Meropenem CRAB C1 16 128 4.0 32 0.50
CRAB C2 16 64 8.0 32 1.00
CRAB C3 16 64 8.0 16 0.75
CRAB C4 32 128 8.0 32 0.50
CRAB C5 16 64 8.0 16 0.75
PapMA-3 + Rifampin CRAB C1 16 128 4.0 8.0 0.31
CRAB C2 16 64 2.0 8.0 0.25
CRAB C3 16 128 4.0 16 0.38
CRAB C4 32 128 2.0(8.0) 8.0(4.0) 0.13(0.27)
CRAB C5 16 256 4.0 64 0.50
PapMA-3 + Erythromycin CRAB C1 16 >512 4.0 128 0.38
CRAB C2 16 512 8.0 128 0.75
CRAB C3 16 512 8.0 64 0.63
CRAB C4 32 >512 4.0(8.0) 64(16) 0.19(0.27)
CRAB C5 16 >512 4.0 256 0.50
PapMA-3 + Vancomycin CRAB C1 16 256 2.0(4.0) 32(16) 0.25(0.31)
CRAB C2 16 256 2.0 32 0.25
CRAB C3 16 256 8.0 4.0 0.52
CRAB C4 32 512 4.0(8.0) 64(16) 0.25(0.28)
CRAB C5 16 256 4.0 64 0.50
PapMA-3 + Linezolid CRAB C1 16 256 4.0 64 0.50
CRAB C2 16 256 4.0 64 0.50
CRAB C3 16 256 8.0 128 1.00
CRAB C4 32 512 8.0 64 0.38
CRAB C5 16 512 4.0 128 0.50

# The fractional inhibitory concentration index (FICI) was calculated according to Equation (1). If the MIC value was not obtained at the highest concentration measured due to poor antibacterial activity, the FICI was considered to be twice the value of the measurement limit. * Combinations that showed synergistic effects are shaded in gray. Where there were multiple sets of combinations with low FICI values, they are listed in parentheses.